<DOC>
	<DOCNO>NCT02558088</DOCNO>
	<brief_summary>The objective study help establish urinary threshold salmeterol World Anti-doping Agency prohibit list , avoid supratherapeutic substance competitive sport . Hence , hypothesis .</brief_summary>
	<brief_title>Pharmacological Properties Salmeterol</brief_title>
	<detailed_description />
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Male 1845 year Healthy Chronic disease Smoking Habitual use medicine Allergy towards salmeterol Unable exercise bike ergometer</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>salmeterol</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>dope</keyword>
	<keyword>beta2-agonists</keyword>
	<keyword>long-acting beta2-agonists</keyword>
</DOC>